Clinical trial
Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis
NCT05133453 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 29, 2024
- Completion date
- February 28, 2026
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.